Treatment of hematological malignancies with nonmyeloablative, HLA-haploidentical bone marrow transplantation and high dose, post-transplantation cyclophosphamide-Reference-Cited by-同舟云学术

Treatment of hematological malignancies with nonmyeloablative, HLA-haploidentical bone marrow transplantation and high dose, post-transplantation cyclophosphamide

Published:2011-09 Issue:3 Volume:24 Page:359-368
ISSN:1521-6926
Container-title:Best Practice & Research Clinical Haematology
language:en
Short-container-title:Best Practice & Research Clinical Haematology

Author:

Munchel Ashley T.,Kasamon Yvette L.,Fuchs Ephraim J.

Funder

National Cancer Institute

Publisher

Elsevier BV

Subject

Clinical Biochemistry,Oncology

Reference54 articles.

1. Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials;Koreth;JAMA: J Am Med Assoc,2009

2. Graft-versus-leukemia reactions after bone marrow transplantation;Horowitz;Blood,1990

3. Non-myeloablative stem cell transplants;Barrett;Br J Haematol,2000

4. HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies;Maris;Blood,2003

5. Graft-versus-tumor effects after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning;Baron;J Clin Oncol,2005

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Low-dose anti-thymocyte globulin plus low-dose posttransplant cyclophosphamide-based regimen for prevention of graft-versus-host disease in haploidentical peripheral blood stem cell transplantation for pediatric patients with hematologic malignancies;Annals of Hematology;2024-07-10

2. Graft-versus-tumor effect of post-transplant cyclophosphamide-based allogeneic hematopoietic cell transplantation;Frontiers in Immunology;2024-06-06

3. Impact of CD34 positive cell dose in donor graft on the outcomes after haploidentical peripheral blood stem cell transplantation with post-transplant cyclophosphamide – A retrospective single-center study with a Japanese cohort;Blood Cells, Molecules, and Diseases;2024-03

4. Human Leukocyte Antigen–Haploidentical Haematopoietic Stem Cell Transplantation Using Post-Transplant Cyclophosphamide for Paediatric Haematological Malignancies;Cancers;2024-01-31

5. Posttransplant cyclophosphamide contributes to the impairment of the graft-versus-leukemia effect and the amelioration of graft-versus-host disease with the suppression of alloreactive T cells in a murine stem cell transplant model;Experimental Hematology;2023-07